JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB227593

Anti-elF2 alpha (phospho S52) 抗体 - N-terminal

Anti-elF2 alpha (phospho S52) antibody - N-terminal

Be the first to review this product! Submit a review

|

(7 Publications)

Rabbit Polyclonal EIF2S1 phospho S52 antibody. N-terminal. Suitable for WB and reacts with Rat, Human samples. Cited in 7 publications. Immunogen corresponding to Synthetic Peptide within Human EIF2S1 phospho S52.

別名を表示する

EIF2A, EIF2S1, Eukaryotic translation initiation factor 2 subunit 1, Eukaryotic translation initiation factor 2 subunit alpha, eIF-2-alpha, eIF-2A, eIF-2alpha, eIF2-alpha

4 Images
Western blot - Anti-elF2 alpha (phospho S52) antibody - N-terminal (AB227593)
  • WB

Supplier Data

Western blot - Anti-elF2 alpha (phospho S52) antibody - N-terminal (AB227593)

10% SDS-PAGE gel.

All lanes:

Western blot - Anti-elF2 alpha (phospho S52) antibody - N-terminal (ab227593) at 1/500 dilution

Lane 1:

HEK-293T (human epithelial cell line from embryonic kidney transformed with large T antigen) whole cell extract at 30 µg

Lane 2:

HEK-293T (human epithelial cell line from embryonic kidney transformed with large T antigen) treated with 25 µg/ml anisomycin for 16 hours, whole cell extract at 30 µg

Predicted band size: 36 kDa

false

Western blot - Anti-elF2 alpha (phospho S52) antibody - N-terminal (AB227593)
  • WB

Supplier Data

Western blot - Anti-elF2 alpha (phospho S52) antibody - N-terminal (AB227593)

10% SDS-PAGE gel.

All lanes:

Western blot - Anti-elF2 alpha (phospho S52) antibody - N-terminal (ab227593) at 1/500 dilution

Lane 1:

HepG2 (human liver hepatocellular carcinoma cell line) whole cell extract at 30 µg

Lane 2:

HepG2 (human liver hepatocellular carcinoma cell line) treated with 3 µM thapsigargin for 12 hours, whole cell extract at 30 µg

Predicted band size: 36 kDa

false

Western blot - Anti-elF2 alpha (phospho S52) antibody - N-terminal (AB227593)
  • WB

Supplier Data

Western blot - Anti-elF2 alpha (phospho S52) antibody - N-terminal (AB227593)

10% SDS-PAGE gel.

All lanes:

Western blot - Anti-elF2 alpha (phospho S52) antibody - N-terminal (ab227593) at 1/500 dilution

Lane 1:

HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell extract at 30 µg

Lane 2:

HeLa (human epithelial cell line from cervix adenocarcinoma) treated with 4 µg/ml tunicamycin for 16 hours, whole cell extract at 30 µg

Predicted band size: 36 kDa

false

Western blot - Anti-elF2 alpha (phospho S52) antibody - N-terminal (AB227593)
  • WB

Supplier Data

Western blot - Anti-elF2 alpha (phospho S52) antibody - N-terminal (AB227593)

10% SDS-PAGE gel.

All lanes:

Western blot - Anti-elF2 alpha (phospho S52) antibody - N-terminal (ab227593) at 1/1000 dilution

Lane 1:

PC-12 (rat adrenal gland pheochromocytoma cell line) whole cell extract at 30 µg

Lane 2:

PC-12 (rat adrenal gland pheochromocytoma cell line) treated with 300 µM thapsigargin for 8 hours, whole cell extract at 30 µg

Predicted band size: 36 kDa

false

Key facts

宿主種

Rabbit

クローン性

Polyclonal

アイソタイプ

IgG

キャリアフリー

No

交差種

Rat, Human

アプリケーション

WB

applications

免疫原

Synthetic Peptide within Human EIF2S1 phospho S52. The exact immunogen used to generate this antibody is proprietary information.

P05198

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/3000", "WB-species-notes": "<p></p>" }, "Rat": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/3000", "WB-species-notes": "<p></p>" } } }

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Immunogen
バッファー組成
pH: 7 Preservative: 0.025% Proclin 300 Constituents: PBS, 20% Glycerol (glycerin, glycerine), 1% BSA
出荷温度
Blue Ice
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

The eIF2 alpha also known as eukaryotic translation initiation factor 2 alpha is a subunit of the eIF2 complex with an approximate mass of 36 kDa. It plays an important role in protein synthesis initiation by facilitating the binding of the initiator methionyl-tRNA to the 40S ribosomal subunit. eIF2 alpha is widely expressed across various tissues indicating its fundamental role in cellular function. It is also regulated through phosphorylation as part of its function in modulation of translation initiation.
Biological function summary

EIF2 alpha modulates protein synthesis in response to cellular stress signals. When phosphorylated eIF2 alpha inhibits the formation of the active eIF2-GTP-Met-tRNA complex reducing general protein translation and facilitating expression of stress-response genes. As part of the eIF2 complex it interacts with other proteins like eIF2β and eIF2γ highlighting its role in translation regulation and cellular response to various stimuli. This control mechanism is important for cellular adaptation to changing environmental conditions.

Pathways

EIF2 alpha plays an important role in the integrated stress response (ISR) and the unfolded protein response (UPR). Phosphorylation of eIF2 alpha by kinases such as PERK and PKR links it to these pathways and demonstrates its key position in cellular stress response networks. eIF2 alpha's activity regulates downstream factors including activating transcription factor 4 (ATF4) which mediates the expression of genes involved in the stress response. This interconnectivity with key signaling pathways highlights its regulatory importance.

Dysregulation of eIF2 alpha phosphorylation links to various pathologies including neurodegenerative diseases and cancer. Aberrant eIF2 alpha activity can result in the misfolding of proteins contributing to diseases like Alzheimer's or lead to uncontrolled cell growth observed in certain cancers. In particular relationships between eIF2 alpha and proteins such as tau in neurodegeneration or MYC in cancer pathogenesis highlight its potential as a therapeutic target for these conditions.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

Member of the eIF2 complex that functions in the early steps of protein synthesis by forming a ternary complex with GTP and initiator tRNA (PubMed : 16289705, PubMed : 38340717). This complex binds to a 40S ribosomal subunit, followed by mRNA binding to form a 43S pre-initiation complex (43S PIC) (PubMed : 16289705). Junction of the 60S ribosomal subunit to form the 80S initiation complex is preceded by hydrolysis of the GTP bound to eIF2 and release of an eIF2-GDP binary complex (PubMed : 16289705). In order for eIF2 to recycle and catalyze another round of initiation, the GDP bound to eIF2 must exchange with GTP by way of a reaction catalyzed by eIF2B (PubMed : 16289705). EIF2S1/eIF2-alpha is a key component of the integrated stress response (ISR), required for adaptation to various stress : phosphorylation by metabolic-stress sensing protein kinases (EIF2AK1/HRI, EIF2AK2/PKR, EIF2AK3/PERK and EIF2AK4/GCN2) in response to stress converts EIF2S1/eIF2-alpha in a global protein synthesis inhibitor, leading to an attenuation of cap-dependent translation, while concomitantly initiating the preferential translation of ISR-specific mRNAs, such as the transcriptional activators ATF4 and QRICH1, and hence allowing ATF4- and QRICH1-mediated reprogramming (PubMed : 19131336, PubMed : 33384352, PubMed : 38340717). EIF2S1/eIF2-alpha also acts as an activator of mitophagy in response to mitochondrial damage : phosphorylation by EIF2AK1/HRI promotes relocalization to the mitochondrial surface, thereby triggering PRKN-independent mitophagy (PubMed : 38340717).
See full target information EIF2S1 phospho S52

文献 (7)

Recent publications for all applications. Explore the full list and refine your search

Nature communications 15:8586 PubMed39362879

2024

Polymeric nanocarrier via metabolism regulation mediates immunogenic cell death with spatiotemporal orchestration for cancer immunotherapy.

Applications

Unspecified application

Species

Unspecified reactive species

Yichen Guo,Yongjuan Li,Mengzhe Zhang,Rong Ma,Yayun Wang,Xiao Weng,Jinjie Zhang,Zhenzhong Zhang,Xiaoyuan Chen,Weijing Yang

In vivo (Athens, Greece) 38:2228-2238 PubMed39187325

2024

17-AAG Induces Endoplasmic Reticulum Stress-mediated Apoptosis in Breast Cancer Cells, Possibly Through PERK/eIF2α Up-regulation.

Applications

Unspecified application

Species

Unspecified reactive species

Prasit Suwannalert,Pimchanok Panpinyaporn,Pitchapa Wantanachaisaeng,Teerapat Teeppaibul,Thanaphat Worawichitchaikun,Thidarat Koomsang,Chonnapat Naktubtim,Witchuda Payuhakrit

Asian journal of andrology 25:152-157 PubMed36629160

2023

deletion stabilizes HIF1α to promote angiogenesis and glycolysis in prostate cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Yu-Zhao Wang,Yu-Chen Qian,Wen-Jie Yang,Lei-Hong Ye,Guo-Dong Guo,Wei Lv,Meng-Xi Huan,Xiao-Yu Feng,Ke Wang,Zhao Yang,Yang Gao,Lei Li,Yu-Le Chen

Reproductive biology and endocrinology : RB&E 19:135 PubMed34496874

2021

Irisin alleviates obesity-related spermatogenesis dysfunction via the regulation of the AMPKα signalling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yang Mu,Huang-Guan Dai,Ling-Bo Luo,Jing Yang

Cell death & disease 12:314 PubMed33762577

2021

Oleandrin, a cardiac glycoside, induces immunogenic cell death via the PERK/elF2α/ATF4/CHOP pathway in breast cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaoxi Li,Jian Zheng,Shi Chen,Fan-Dong Meng,Jing Ning,Shu-Lan Sun

The Journal of pharmacology and experimental therapeutics 377:146-156 PubMed33509902

2021

Apigenin Ameliorates Insulin Resistance and Lipid Accumulation by Endoplasmic Reticulum Stress and SREBP-1c/SREBP-2 Pathway in Palmitate-Induced HepG2 Cells and High-Fat Diet-Fed Mice.

Applications

Unspecified application

Species

Unspecified reactive species

Liling Wu,Tingdong Guo,Ranxi Deng,Lusheng Liu,Yongxiong Yu

Molecular medicine reports 17:7886-7892 PubMed29620275

2018

Effects of endoplasmic reticulum stress on autophagy and apoptosis of human leukemia cells via inhibition of the PI3K/AKT/mTOR signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Li-Juan Li,Ye Chai,Xiao-Jia Guo,Song-Lin Chu,Lian-Sheng Zhang
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com